Indeed, it was recently reported that SK2 activity promoted cell migration and invasion in pancreatic cancer cells by enhancing an integrin–EGFR–AKT (Protein kinase B) pathway [22, 43]. This evidence concerns the gene EGFR and familial pancreatic carcinoma.